CFTC and SEC Seek Whistleblowers to Expose Investment Fraud, Insider Trading, and Securities Fraud

The Commodity Futures Trading Commission (CFTC) and the Securities and Exchange Commission (SEC) Are Offering Large Rewards and Bounties to Whistleblowers That Properly Expose Hedge Fund Fraud, Investment Fraud, Insider Trading, False Accounting, Investment Derivative Fraud, Government Official Bribes, and Securities Fraud by Hedge Fund Fraud Whistleblower Lawyer, Securities Fraud Whistleblower Lawyer, Insider Trading Whistleblower Lawyer, and Investment Derivatives Fraud Whistleblower Lawyer Jason S. Coomer

The Commodity Futures Trading Commission (CFTC) and the Securities and Exchange Commission (SEC) are offering large financial rewards and bounties to whistleblowers that properly expose hedge fund fraud, securities fraud, corporate false accounting, government official bribes, and corruption in the Financial Services Industry.  These new Whistleblower Bounty Laws have been enacted to encourage financial services professionals, high end investors, government officials, regulators, and other individuals with knowledge of securities fraud, hedge fund fraud, derivatives fraud, financial services government bribes, investment fraud, corporate false accounting, and other SEC violations and CFTC violations, to expose the fraud and corruption.  These new whistleblower reward laws offer large financial rewards and whistleblower protections for persons including international whistleblowers that qualify and expose significant fraud and corruption.

Statement on the Application of Insider Trading Law to Trading by Members of Congress and Their Staffs

The Commodity Futures Trading Commission (CFTC) and the Securities and Exchange Commission (SEC) are offering large financial rewards and bounties to International Whistleblowers that properly expose international hedge fund fraud, international securities fraud, corporate false accounting, government official bribes, and corruption in the Financial Services Industry.

Insider trading has long been a high priority for the Commission. Approximately eight percent of the 650 average annual number of enforcement cases filed by the Commission in the past decade have been for insider trading violations. In the past two years, the Commission has been particularly active in this area. In fiscal year 2010, the SEC brought 53 insider trading cases against 138 individuals and entities, a 43 percent increase in the number of filed cases from the prior fiscal year. This past fiscal year, the Commission filed 57 actions against 124 individuals and entities, a nearly 8 percent increase over the number of filed cases in fiscal year 2010.

The increased number of insider trading cases has been matched by an increase in the quality and significance of our recent cases. In fiscal year 2011 and the early part of fiscal year 2012, the SEC obtained judgments in 18 actions arising out of its investigation of Galleon hedge fund founder Raj Rajaratnam, including a record $92.8 million civil penalty against Rajaratnam personally. The SEC also discovered and developed information that ultimately led to criminal convictions of Rajaratnam and others, including corporate executives and hedge fund managers, for rampant insider trading. In addition, we recently filed an insider trading action against Rajat Gupta, a former director of both Goldman Sachs and Procter & Gamble, whom we allege provided confidential Board information about both companies’ quarterly earnings and about an impending $5 billion Berkshire Hathaway investment in Goldman Sachs to Rajaratnam, who traded on that information.

Among others charged in SEC insider trading cases in the past fiscal year were various hedge fund managers and traders involved in a $30 million expert networking trading scheme, a former Nasdaq Managing Director, a former Major League Baseball player, a Food and Drug Administration chemist, and a former corporate attorney and a Wall Street trader who traded in advance of mergers involving clients of the attorney’s law firm. The SEC also brought insider trading cases charging a Goldman Sachs employee and his father with trading on confidential information learned by the employee on the firm’s ETF desk, and charging a corporate board member of a major energy company and his son for trading on confidential information about the impending takeover of the company.

The SEC Is Offering Large Financial Bounties For Whistleblowers That Properly Expose Executive Insider Trading, Hedge Fund Insider Trading, Private Equity Fund Fraud, Money Manger Insider Trades, Hedge Fund Manager Illegal Trading, Stock Manipulation Schemes, and Other Violations of Securities Law by Hedge Fund Insider Trade Whistleblower Lawyer, Private Equity Fund Insider Trade Whistleblower Lawyer, Stock Manipulation Scheme Whistleblower Lawyer, & Executive Illegal Insider Trade Whistleblower Lawyer Jason Coomer

The SEC Is Offering Large Financial Bounties For Whistleblowers That Properly Expose Executive Insider Trading, Hedge Fund Insider Trading, Private Equity Fund Fraud, Money Manger Insider Trades, Hedge Fund Manager Illegal Trading, Stock Manipulation Schemes, and Other Violations of Securities Law by Hedge Fund  Insider Trade Whistleblower Lawyer, Private Equity Fund Insider Trade Whistleblower Lawyer, Stock Manipulation Scheme Whistleblower Lawyer, & Executive Illegal Insider Trade Whistleblower Lawyer Jason Coomer

The SEC is offering large financial bounties to insider trade whistleblowers that expose executive insider trading, hedge fund insider trading, private equity fund fraud, money manger insider trading, hedge fund manager illegal trading, stock manipulation schemes, and other violations of securities law.  These insider trading whistleblower rewards can be obtained by financial professionals with knowledge of illegal insider trading and other SEC violations.  The SEC encourages all financial professionals with original knowledge of executive insider trades, hedge fund insider trades, private equity fund fraud, false misleading information on a company's financial statements, false information on Securities and Exchange Commission (SEC) filings, stock manipulation schemes; embezzlement by stockbrokers; and other securities fraud to properly expose the violations.  

For many financial professionals, it can be a difficult decision to step forward to expose executive insider trades, hedge fund insider trades, private equity fund fraud, false misleading information on a company's financial statements, false information on Securities and Exchange Commission (SEC) filings, stock manipulation schemes; embezzlement by stockbrokers; and other securities fraud.  To protect these professionals, confidentiality safeguards have been put in place that allow the financial professional whistleblower to blow the whistle on securities fraud through an attorney.  

Dueling Portrayals of Former Goldman Director at Insider Trading Trial - NYTimes.com

Mr. Gupta, a former director of Goldman Sachs and Procter & Gamble, stands accused of leaking boardroom secrets about those two companies to his friend and business associate Raj Rajaratnam, the convicted former money manager who ran the Galleon Group, once one of the world’s largest hedge funds.  The government depicted Mr. Gupta, a resident of Westport, Conn., as the ultimate insider who, after running the elite consulting firm McKinsey & Company, joined the boards of Goldman and P.& G. As a director, he was privy to these companies’ most closely guarded secrets.

“Gupta threw away his duties, threw away his responsibilities and broke the law,” Mr. Brodsky said.
Mr. Brodsky emphasized the ties between Mr. Gupta and Mr. Rajaratnam, who began doing business together during the middle of the last decade. Mr. Gupta invested in Galleon’s funds, and the two helped start a $1 billion private equity fund together.

“Together they offered each other far more than they could achieve individually,” said Mr. Brodsky.

International Whistleblowers Are Receiving Large Rewards for Exposing Government Procurement Bribe Schemes and other Government Corruption by International Government Procurement Bribe Whistleblower Lawyer, International Procurement Contract Bribe Lawyer, and International Procurement Illegal Kickback Whistleblower Attorney Jason S. Coomer

International Whistleblowers Are Receiving Large Rewards for Exposing Government Procurement Bribe Schemes and other Government Corruption by International Government Procurement Bribe Whistleblower Lawyer, International  Procurement Contract Bribe Lawyer, and International Procurement Illegal Kickback Whistleblower Attorney Jason S. Coomer

Worldwide government purchasing or government procurement is estimated to be over $10 Trillion each year.  Of this large amount of government purchasing, it is estimated that as much as 20% may be through illegal bribes, kickbacks, and other illicit payments.  Government procurement spending includes military spending; public works projects; public health care (pharmaceuticals, medical equipment, & hospitals); ports, transportation, & roads; mining and oil extraction; power grid and stations; education; law enforcement; and sanitation services.  Because of the vast amount of money spent by governments on government procurement, there are many different types of government procurement illegal bribery schemes, illegal kickback schemes, and other illicit payment schemes that have been created to steal money from the public at the expense of a country's citizens.

International Executives, Government Officials, Employees of International Corrupt Corporations, Competitors of Corrupt International Corporations, Foreign Nationals, and other Persons With Original Source Knowledge of International Procurement Bribes Can Be Eligible for Foreign Corrupt Practices Whistleblower Rewards by Government Procurement Bribe Lawyer, Procurement Contract Bribe Lawyer, and Procurement Illegal Kickback Whistleblower Lawyer Jason S. Coomer

International government procurement whistleblowers can recover large amounts of money for exposing international government procurement kickback schemes, international government bribery schemes, and other violations of the Foreign Corrupt Practices Act.  Some types of these international government procurement illegal bribery schemes, international illegal kickback schemes, and other international illicit payment schemes are discussed in more detail below.

International executives, government officials, employees of international corrupt corporations, competitors of corrupt international corporations, and other persons, who are the original source of specialized knowledge of international government procurement bribes, international public works illegal kickback schemes, public health system procurement bribery schemes, and other illicit payments are encouraged to blow the whistle on international government procurement schemes and may be able to collect large financial rewards for exposing the corruption. 

The Federal Government and Several States Are Going After Pharmaceutical Companies That Fraudulently Market and Target Medicaid, Medicare, and Public Health Programs by Drug Company Marketing Fraud Whistleblower Lawyer, Pharmaceutical Professional Whistleblower Lawyer, Drug Company Whistleblower Medicaid Fraud Lawyer, & Drug Company Whistleblower Illegal Kickback Lawyer

The Federal Government and Several States Are Going After Pharmaceutical Companies That Fraudulently Market and Target Medicaid, Medicare, and Public Health Programs by Drug Company Marketing Fraud Whistleblower Lawyer, Pharmaceutical Professional Whistleblower Lawyer, Drug Company Whistleblower Medicaid Fraud Lawyer, & Drug Company Whistleblower Illegal Kickback Lawyer

The United States Department of Justices, Texas Attorney General, and state attorney general offices from several other states are working with Drug Company Professionals on Marketing Fraud Whistleblower Lawsuits and have begun enforcing new Medicaid fraud whistleblower recovery laws to help clean up corruption and health care fraud.  Through these new whistleblower laws and with information provided by drug company professionals through drug company whistleblower Medicaid fraud lawyers, these Medicaid fraud whistleblowers, the Department of Justices, drug company whistleblower Medicaid fraud lawyers, and state attorney generals are making large recoveries from drug companies, pharmacies, and other health care providers that have been systematically defrauding state Medicaid programs, Medicare, and other public health care programs.

USDOJ: Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote

Global Health Care Company Abbott Laboratories Inc. has pleaded guilty and agreed to pay $1.5 billion to resolve its criminal and civil liability arising from the company’s unlawful promotion of the prescription drug Depakote for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Justice Department announced today.  The resolution – the second largest payment by a drug company – includes a criminal fine and forfeiture totaling $700 million and civil settlements with the federal government and the states totaling $800 million.  Abbott also will be subject to court-supervised probation and reporting obligations for Abbott’s CEO and Board of Directors.

The Federal Government and Several States Including Texas Are Making Large Recoveries Through Medicaid Drug Marketing Fraud Whistleblower Lawsuits and Medicaid Drug Price Fraud Whistleblower Lawsuits by Drug Company Marketing Fraud Whistleblower Lawyer, Pharmaceutical Professional Whistleblower Lawyer, Drug Company Whistleblower Medicaid Fraud Lawyer, & Drug Company Whistleblower Illegal Kickback Lawyer

In January 2012, the State of Texas and a Medicaid drug marketing fraud  whistleblower squared off against Johnson and Johnson, Inc. and several related companies in Travis County District Court.  In the case, the State of Texas alleged that the large drug company systematically targeted the Texas Medicaid System and fraudulently misrepresented their drug, Risperdal, with false and misleading marketing information.  Further, that the defendants intentionally targeted opinion leaders in the medical community with financial incentives and misleading information in an effort to have the drug placed into treatment guidelines, model state treatment programs, formularies, Texas Vendor Drug Programs, and the Texas Medicaid preferred drug lists.

Attorneys for the State of Texas and Medicaid Marketing Fraud Whistleblower argued that they had reviewed millions of documents and could prove that the large drug company intentionally pushed Risperdal as a safer alternative to the typical medications despite rulings from the Food and Drug Administration that these assertions were not supported by scientific research.  Further, that the defendants orchestrated a fraudulent marketing scheme to seed medical literature with misleading information and influence key medical decision makers to increase Risperdal in the Texas Medicaid Program as well as used this information to push their drug as the established treatment in state Medicaid programs throughout the United States as well as in the Federal Medicare program.

As a result of this Texas lawsuit, the drug maker, Johnson and Johnson, Inc., agreed to settle the Texas Medicaid fraud case for $158 million.  Johnson and Johnson, Inc. has also agreed to a settlement where the drug company will will pay more than $1 billion in civil and criminal penalties to the federal government and individual states to settle an investigation into the marketing practices of its anti-psychotic drug Risperdal.  Johnson and Johnson, Inc. has also been hit in Medicaid fraud cases in South Carolina and Louisiana and was ordered to pay more than $250 million each.

International Health Care Procurement Whistleblowers Are Receiving Large Rewards for Exposing Government Health Care Procurement Bribe Schemes & other Government Procurement Corruption by International Government Health Care Procurement Bribe Whistleblower Lawyer, International Health Care Procurement Contract Bribe Lawyer, & International Pharmaceutical Procurement Illegal Kickback Whistleblower Attorney Jason Coomer

International Procurement Whistleblowers Are Receiving Large Rewards for Exposing Government Health Care Procurement Bribe Schemes and other Government Procurement Corruption by International Government Health Care Procurement Bribe Whistleblower Lawyer, International Pharmaceutical Procurement Contract Bribe Lawyer, and International Health Care Procurement Illegal Kickback Whistleblower Attorney Jason S. Coomer

Worldwide government purchasing or government procurement is estimated to be over $10 Trillion each year.  Of this large amount of government purchasing, it is estimated that as much as 20% may be through illegal bribes, kickbacks, and other illicit payments.  Government procurement spending includes military spending; public works projects; public health care (pharmaceuticals, medical equipment, & hospitals); ports, transportation, & roads; mining and oil extraction; power grid and stations; education; law enforcement; and sanitation services.  Because of the vast amount of money spent by governments on government procurement, there are many different types of government procurement illegal bribery schemes, illegal kickback schemes, and other illicit payment schemes that have been created to steal money from the public at the expense of a country's citizens.

Chinese Health-Care System Rife With Corruption Risks - Corruption Currents - WSJ

"Western companies seeking to find their way into China’s largely state-run health care system face heightened risks now that the Chinese government is planning to investigate drug-procurement and medical-device tendering. The tendering and procurement process is opaque and fragmented, giving companies more headaches when they try to enter the market, experts said."

"It becomes a bigger problem given news that China’s government, according to recent reports, is going to start inspecting hospitals’ invoices in a bid to curb commercial bribery and money laundering during the procurement process."

"The U.S. Justice Department has been in the middle of sweeping probes into both the pharmaceutical and medical-device industries. For example, orthopedic manufacturer Biomet Inc. agreed in March to pay the U.S. $22 million to settle FCPA charges that the company paid more than $1.5 million in direct and indirect payments to employees of state-owned health care providers in Argentina, Brazil and China to secure lucrative business with hospitals. The company didn’t enter a guilty plea, but accepted responsibility for the allegations laid out in court documents."

 International Health Care Procurement Whistleblowers Are Needed to Expose Government Health Care Procurement Bribe Schemes and other Government Procurement Corruption by International Government Medicine Procurement Bribe Whistleblower Lawyer, International Drug Procurement Contract Bribe Lawyer, and International Health Care Procurement Illegal Kickback Whistleblower Attorney Jason S. Coomer

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications.  In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to 7% to around $880 billion.  This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland and the Ukraine.  These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

Eight pharmerging countries are amongst the top 20 world pharmaceutical markets, and China is one of the “top three” or will be in the near future.  A few high-profile pharmaceutical companies have been successful in gaining a foothold in these pharmering countries.  These footholds include Abbott’s acquisition of Piramal Healthcare in India — a deal that could potentially make the US giant the top player in this country.  Bayer's and Novartis' investments in China including Novartis'  commitment to invest $1 billion USD in R&D in China and its $125 million USD investment to buy 85 percent stake in a privately held vaccine company.  Pfizer has made inroads into the Russian health care system with a discount-card system in Russia  Sanofi Aventis has purchased Medley, Brazil’s third-largest pharmaceutical company.  GSK and Lilly have also announced anticipated doubling their revenue in emerging markets by 2015.

International Health Care Whistleblowers Are Exposing Government Health Care Procurement Bribe Schemes and other Government Procurement Corruption by International Government Health Care Procurement Bribe Whistleblower Lawyer, International Pharmaceutical Procurement Contract Bribe Lawyer, and International Health Care Procurement Illegal Kickback Whistleblower Attorney Jason S. Coomer

International Whistleblowers along the pharmaceutical supply chain and other health care professionals are being offered large potential rewards to blow the whistle on adulterated pharmaceutical ingredients, adulterated medicine, adulterated drugs, contaminated medical supplies, and defective medical devices.  These whistleblower rewards can come from SEC Whistleblower Reward Lawsuits and traditional Qui Tam False Claims Act Whistleblower Reward Lawsuits.  For more information on these potential whistleblower rewards, feel free to go to the following web pages: Government Contractor Procurement Fraud Lawsuits and International Government Procurement Bribe Whistleblower Rewards, International Procurement Bribe Whistleblower Lawsuits.

Securities and Exchange Commission Whistleblower Reward Law Designed to Expose Financial Fraud and Investment Fraud

Matthew H. Kluger and Garrett D. Bauer

Securities and Exchange Commission v. Matthew H. Kluger and Garrett D. Bauer, Case No. 11-cv-1936 (D.N.J. April 6, 2011) (KSH-PS); Securities and Exchange Commission v. Kenneth T. Robinson, Case No. 12-cv-2438 (D.N.J. April 25, 2011) (KSH-PS)

ATTORNEY, WALL STREET TRADER, AND MIDDLEMAN SETTLE SEC CHARGES IN $32 MILLION INSIDER TRADING CASE

Washington, D.C., April 25, 2012 – The Securities and Exchange Commission today announced a settlement in a $32 million insider trading case filed by the agency last year against a corporate attorney and a Wall Street trader.

The SEC alleged that the insider trading occurred in advance of at least 11 merger and acquisition announcements involving clients of the law firm where the attorney – Matthew H. Kluger – worked. He and the trader – Garrett D. Bauer – were linked through a mutual friend now identified as Kenneth T. Robinson, who acted as a middleman to facilitate the illegal tips and trades. Kluger and Bauer used public telephones and prepaid disposable mobile phones to communicate with Robinson in an effort to avoid detection. Robinson, now also charged, cooperated in the SEC’s investigation.
Bauer, Kluger, and Robinson each agreed to give up their ill-gotten gains plus interest in order to settle the SEC’s charges. Those amounts under the terms of their consent agreements are approximately $31.6 million for Bauer, $516,000 for Kluger, and $845,000 for Robinson.

Securities and Exchange Commission Whistleblower Reward Law Designed to Expose Financial Fraud and Investment Fraud

 Two relatively new whistleblower recovery laws are section 21F of the Securities Exchange Act (SEC Whistleblower Bounty Actions), and section 23 of the Commodity Exchange Act (CFTC Whisteblower Bounty Actions).    These laws were passed in the wake of Financial Market Melt Down in 2008 and in response to massive fraud in the financial markets.  These whistleblower recovery laws are designed to encourage people with specialized knowledge of significant investment fraud, securities fraud, SEC violations, commodity futures fraud, violations of the foreign corrupt practices act, and other financial fraud.  These whistleblower reward laws were designed to protect whistleblowers that step up and blow the whistle on financial fraud.

International Theft of Trade Secrets, International Patent Infringement, and International Intellectual Property Rights Infringement are on the Rise by International Patent Infringement Government Procurement Whistleblower Reward Lawyer, International Trade Secret Theft Procurement Whistleblower Lawyer, and International Patent Infringement Supply Chain Import Business Litigation Lawyer Jason S. Coomer

International Theft of Trade Secrets, International Patent Infringement, and International Intellectual Property Rights Infringement are on the Rise by International Patent Infringement Government Procurement Whistleblower Reward Lawyer, International Trade Secret Theft Procurement Whistleblower Lawyer, and International Patent Infringement Supply Chain Import Business Litigation Lawyer Jason S. Coomer

International theft of trade secrets and international intellectual property right infringement are on the rise as China, Mexico, Russia, and other emerging countries are seeking to improve their technology to move up the manufacturing value chain.  With fierce competition from countries such as Vietnam, Cambodia and Bangladesh attempting to undercut China's manufacturing of labor-intensive goods as well as higher end supply chain manufacturing competition from other emerging countries being placed on China, Russia, and Mexico; the pressure to obtain high end trade secrets and intellectual property has led to corporate espionage and theft of valuable trade secrets and intellectual property.  These products when used in other products can come through the supply chain and be the basis for patent infringement lawsuits, whistleblower reward lawsuits, and other types of lawsuits.

International Patent Infringement Government Procurement Reward Lawsuits, International Trade Secret Theft Government Procurement Whistleblower Reward Lawsuits, International Supply Chain Procurement Fraud Whistleblower Lawsuits, International Patent Infringement Qui Tam Lawsuits, and International Business Litigation Lawsuits

International theft of trade secret lawsuits, international patent infringement lawsuits, international intellectual property right infringement lawsuits, and other international business litigation lawsuits can be complicated legal matters requiring an experienced legal team to work across jurisdictions and work with different government entities.   These cases can become procurement fraud whistleblower reward lawsuits when internationally produced products reenter the United States and are sold to the U.S. Government or another governmental entity.

---

Establish U.S. Government-Wide Working Group to Prevent U.S. Government Purchase of Counterfeit Products
The 2011 IPEC Annual Report on Intellectual Property Enforcement

As the purchaser of over $500 billion in goods and services per year, the U S Government must ensure that it does not purchase counterfeit goods, secure its supply chain, and take the necessary steps to combat the evolving tactics of counterfeiters The Joint Strategic Plan established a government-wide working group to prevent the purchase and use of counterfeit products Over the last year, the IPEC convened an interagency group consisting of subject matter experts to develop an anti-counterfeiting framework that is flexible enough to accommodate the wide variety of missions across the government and their different systems of procurement The Office of Federal Procurement Policy (OFPP), Department of Defense (DOD), DOJ, and NASA have assumed leadership roles within the working group based on their vast expertise with U S Government procurement and anti-counterfeiting practices Other members include the DOC, Department of Energy, HHS, DHS, and Department of Transportation, the Environmental Protection Agency, the Missile Defense Agency, the General Services Administration, the Small Business Administration, the Nuclear Regulatory Commission, and the National Reconnaissance Office The main focus of this interagency working group is to ensure that the U S Government has the necessary tools to ensure that it does not purchase or use counterfeit products The working group is examining legislative authority, regulations, procurement policy and guidance, industry studies and reports, and international anti-counterfeiting standards in order to identify areas where risk to the security of U S Government supply chain from counterfeit parts can be reduced The working group developed six objectives to focus the group’s efforts to identify legislative, regulatory, or policy gaps and propose solutions to fill those gaps The six objectives are:

• Counterfeit Risk Assessment
• Supplier Requirements
• Traceability
• Testing and Evaluation of Goods
• Counterfeit Training and Outreach
• Enforcement Remedies

The group is developing a government-wide strategy using tools that are already at the U S Government’s disposal and creating new tools to combat the purchase or use of counterfeit goods by the U S Government The strategy will focus on reducing the risk of counterfeit items entering the supply chain, dealing efficiently with any suspected counterfeit items that do enter the supply chain, and strengthening remedies against those who provide counterfeit items to the U S Government.

International Patent Infringement Government Procurement Reward Lawsuits, International Trade Secret Theft Government Procurement Whistleblower Reward Lawsuits, International Supply Chain Procurement Fraud Whistleblower Lawsuits, International Patent Infringement Qui Tam Lawsuits, and International Business Litigation Lawsuits

For more information on International Patent Infringement Government Procurement Reward Lawsuits, International Trade Secret Theft Government Procurement Whistleblower Reward Lawsuits, International Supply Chain Procurement Fraud Whistleblower Lawsuits, International Patent Infringement Qui Tam Lawsuits, please click on the following link: International Patent Infringement Government Procurement Reward Lawsuit, International Trade Secret Theft Government Procurement Whistleblower Reward Lawsuit, International Supply Chain Procurement Fraud Whistleblower Lawsuit, and International Patent Infringement Qui Tam Lawsuit Information

International theft of trade secret lawsuits,